Curaleaf Holdings, Inc. (CURLF) stock
CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$7.63−0.20 (-2.55%)
Close on Oct 19, 2026Market cap $2.07BP/E –Yield –
Curaleaf r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $805.00K, down 43.3% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $805.00K | -43.3% |
| FY2024 | Dec 31, 2024 | $1.42M | – |
See a number that looks wrong?